{
    "N/R/U": null,
    "Applicant": "Tanvex BioPharma USA, Inc.",
    "BLA Number": "761126",
    "Proprietary Name": "Nypozi",
    "Proper Name": "filgrastim-txid",
    "BLA Type": "351(k) Biosimilar",
    "Strength": "300MCG/0.5ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous, Subcutaneous",
    "Product Presentation": "Pre-Filled Syringe",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "June 28, 2024",
    "Ref. Product Proper Name": "filgrastim",
    "Ref. Product Proprietary Name": "Neupogen",
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2259",
    "Product Number": "001",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}